Fig. 2From: CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in JapanProgression-free survival (a) and overall survival (b) in the CD34-selected group and the unmanipulated groupBack to article page